EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA
Clinical trial NCT00562588 · COMPLETED
Trial details
- NCT number
- NCT00562588
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-02-01
- Enrollment
- 551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.